IO Biotech, Inc.
IOBT
$0.64
$0.011.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.66M | 28.13M | 37.09M | 60.03M | 80.19M |
| Total Receivables | 991.00K | 1.14M | 922.00K | 1.13M | 964.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 287.00K | 639.00K | 960.00K | 1.12M | 252.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.89M | 9.07M | 3.37M | 2.67M | 4.84M |
| Total Current Assets | 36.83M | 38.98M | 42.34M | 64.95M | 86.24M |
|
|
|||||
| Total Current Assets | 36.83M | 38.98M | 42.34M | 64.95M | 86.24M |
| Net Property, Plant & Equipment | 1.85M | 2.07M | 2.20M | 2.36M | 2.51M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.28M | 1.27M | 1.19M | 385.00K | 1.19M |
| Total Assets | 39.96M | 42.33M | 45.74M | 67.70M | 89.95M |
|
|
|||||
| Total Accounts Payable | 5.59M | 5.54M | 5.20M | 4.66M | 5.26M |
| Total Accrued Expenses | 11.45M | 13.18M | 11.85M | 13.61M | 9.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 788.00K | 768.00K | 735.00K | 717.00K | 694.00K |
| Total Finance Division Other Current Liabilities | 491.00K | 416.00K | 506.00K | 500.00K | 937.00K |
| Total Other Current Liabilities | 491.00K | 416.00K | 506.00K | 500.00K | 937.00K |
| Total Current Liabilities | 18.31M | 19.90M | 18.29M | 19.49M | 16.06M |
|
|
|||||
| Total Current Liabilities | 18.31M | 19.90M | 18.29M | 19.49M | 16.06M |
| Long-Term Debt | 16.66M | 6.72M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 667.00K | 868.00K | 1.03M | 1.20M | 1.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.40M | 13.25M | -- | -- | -- |
| Total Liabilities | 39.05M | 40.73M | 19.31M | 20.68M | 17.38M |
|
|
|||||
| Common Stock & APIC | 424.41M | 416.36M | 414.75M | 413.18M | 411.55M |
| Retained Earnings | -416.33M | -407.95M | -381.73M | -359.31M | -327.98M |
| Treasury Stock & Other | -7.17M | -6.81M | -6.59M | -6.85M | -11.00M |
| Total Common Equity | 911.00K | 1.59M | 26.42M | 47.02M | 72.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 911.00K | 1.59M | 26.42M | 47.02M | 72.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 911.00K | 1.59M | 26.42M | 47.02M | 72.57M |
|
|
|||||